Annual CFF
-$459.60 M
-$166.00 M-56.54%
31 December 2023
Summary:
West Pharmaceutical Services annual cash flow from financing activities is currently -$459.60 million, with the most recent change of -$166.00 million (-56.54%) on 31 December 2023. During the last 3 years, it has fallen by -$322.50 million (-235.23%). WST annual CFF is now -481.41% below its all-time high of $120.50 million, reached on 31 December 2005.WST Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$64.40 M
+$153.90 M+70.50%
30 September 2024
Summary:
West Pharmaceutical Services quarterly cash flow from financing activities is currently -$64.40 million, with the most recent change of +$153.90 million (+70.50%) on 30 September 2024. Over the past year, it has dropped by -$42.10 million (-188.79%). WST quarterly CFF is now -149.27% below its all-time high of $130.70 million, reached on 31 March 2007.WST Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$743.20 M
-$42.10 M-6.00%
30 September 2024
Summary:
West Pharmaceutical Services TTM cash flow from financing activities is currently -$743.20 million, with the most recent change of -$42.10 million (-6.00%) on 30 September 2024. Over the past year, it has dropped by -$463.60 million (-165.81%). WST TTM CFF is now -716.76% below its all-time high of $120.50 million, reached on 31 December 2005.WST TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
WST Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -56.5% | -188.8% | -165.8% |
| 3 y3 years | -235.2% | -1010.3% | -335.6% |
| 5 y5 years | -469.5% | -10000.0% | -674.2% |
WST Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -235.2% | at low | -1010.3% | +76.2% | -342.1% | at low |
| 5 y | 5 years | -1148.9% | at low | -226.3% | +76.2% | -1919.6% | at low |
| alltime | all time | -481.4% | at low | -149.3% | +76.2% | -716.8% | at low |
West Pharmaceutical Services Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$64.40 M(-70.5%) | -$743.20 M(+6.0%) |
| June 2024 | - | -$218.30 M(-19.4%) | -$701.10 M(+6.3%) |
| Mar 2024 | - | -$271.00 M(+43.0%) | -$659.60 M(+43.5%) |
| Dec 2023 | -$459.60 M(+56.5%) | -$189.50 M(+749.8%) | -$459.60 M(+64.4%) |
| Sept 2023 | - | -$22.30 M(-87.4%) | -$279.60 M(-15.9%) |
| June 2023 | - | -$176.80 M(+149.0%) | -$332.50 M(+73.3%) |
| Mar 2023 | - | -$71.00 M(+647.4%) | -$191.90 M(-34.6%) |
| Dec 2022 | -$293.60 M(+74.7%) | -$9.50 M(-87.4%) | -$293.60 M(+1.1%) |
| Sept 2022 | - | -$75.20 M(+107.7%) | -$290.30 M(+31.4%) |
| June 2022 | - | -$36.20 M(-79.0%) | -$220.90 M(+19.8%) |
| Mar 2022 | - | -$172.70 M(+2685.5%) | -$184.40 M(+9.7%) |
| Dec 2021 | -$168.10 M(+22.6%) | -$6.20 M(+6.9%) | -$168.10 M(-1.5%) |
| Sept 2021 | - | -$5.80 M(-2033.3%) | -$170.60 M(-0.8%) |
| June 2021 | - | $300.00 K(-100.2%) | -$172.00 M(-0.7%) |
| Mar 2021 | - | -$156.40 M(+1697.7%) | -$173.20 M(+26.3%) |
| Dec 2020 | -$137.10 M(+272.6%) | -$8.70 M(+20.8%) | -$137.10 M(+77.1%) |
| Sept 2020 | - | -$7.20 M(+700.0%) | -$77.40 M(+9.6%) |
| June 2020 | - | -$900.00 K(-99.3%) | -$70.60 M(+6.0%) |
| Mar 2020 | - | -$120.30 M(-335.9%) | -$66.60 M(+81.0%) |
| Dec 2019 | -$36.80 M(-54.4%) | $51.00 M(<-9900.0%) | -$36.80 M(-61.7%) |
| Sept 2019 | - | -$400.00 K(-112.9%) | -$96.00 M(+12.3%) |
| June 2019 | - | $3.10 M(-103.4%) | -$85.50 M(-25.2%) |
| Mar 2019 | - | -$90.50 M(+1003.7%) | -$114.30 M(+41.6%) |
| Dec 2018 | -$80.70 M(-26.0%) | -$8.20 M(-181.2%) | -$80.70 M(-49.2%) |
| Sept 2018 | - | $10.10 M(-139.3%) | -$159.00 M(-7.6%) |
| June 2018 | - | -$25.70 M(-54.8%) | -$172.10 M(+19.4%) |
| Mar 2018 | - | -$56.90 M(-34.2%) | -$144.10 M(+32.2%) |
| Dec 2017 | -$109.00 M(-4.3%) | -$86.50 M(+2783.3%) | -$109.00 M(+122.9%) |
| Sept 2017 | - | -$3.00 M(-230.4%) | -$48.90 M(-19.7%) |
| June 2017 | - | $2.30 M(-110.6%) | -$60.90 M(-13.7%) |
| Mar 2017 | - | -$21.80 M(-17.4%) | -$70.60 M(-38.0%) |
| Dec 2016 | -$113.90 M(+174.5%) | -$26.40 M(+76.0%) | -$113.90 M(+27.8%) |
| Sept 2016 | - | -$15.00 M(+102.7%) | -$89.10 M(-14.7%) |
| June 2016 | - | -$7.40 M(-88.6%) | -$104.50 M(-3.1%) |
| Mar 2016 | - | -$65.10 M(+3968.8%) | -$107.80 M(+159.8%) |
| Dec 2015 | -$41.50 M(+34.7%) | -$1.60 M(-94.7%) | -$41.50 M(-0.5%) |
| Sept 2015 | - | -$30.40 M(+184.1%) | -$41.70 M(+95.8%) |
| June 2015 | - | -$10.70 M(-991.7%) | -$21.30 M(-61.8%) |
| Mar 2015 | - | $1.20 M(-166.7%) | -$55.80 M(+81.2%) |
| Dec 2014 | -$30.80 M(+503.9%) | -$1.80 M(-82.0%) | -$30.80 M(-41.3%) |
| Sept 2014 | - | -$10.00 M(-77.9%) | -$52.50 M(+33.2%) |
| June 2014 | - | -$45.20 M(-272.5%) | -$39.40 M(+14.5%) |
| Mar 2014 | - | $26.20 M(-211.5%) | -$34.40 M(+574.5%) |
| Dec 2013 | -$5.10 M(+50.0%) | -$23.50 M(-858.1%) | -$5.10 M(-54.1%) |
| Sept 2013 | - | $3.10 M(-107.7%) | -$11.10 M(+70.8%) |
| June 2013 | - | -$40.20 M(-172.4%) | -$6.50 M(-123.3%) |
| Mar 2013 | - | $55.50 M(-288.1%) | $27.90 M(-920.6%) |
| Dec 2012 | -$3.40 M(-86.2%) | -$29.50 M(-483.1%) | -$3.40 M(+70.0%) |
| Sept 2012 | - | $7.70 M(-232.8%) | -$2.00 M(-44.4%) |
| June 2012 | - | -$5.80 M(-124.0%) | -$3.60 M(+500.0%) |
| Mar 2012 | - | $24.20 M(-186.1%) | -$600.00 K(-97.6%) |
| Dec 2011 | -$24.70 M(-27.4%) | -$28.10 M(-560.7%) | -$24.70 M(+120.5%) |
| Sept 2011 | - | $6.10 M(-317.9%) | -$11.20 M(-47.9%) |
| June 2011 | - | -$2.80 M(-2900.0%) | -$21.50 M(-23.2%) |
| Mar 2011 | - | $100.00 K(-100.7%) | -$28.00 M(-17.6%) |
| Dec 2010 | -$34.00 M(+50.4%) | -$14.60 M(+247.6%) | -$34.00 M(-7.9%) |
| Sept 2010 | - | -$4.20 M(-54.8%) | -$36.90 M(-0.5%) |
| June 2010 | - | -$9.30 M(+57.6%) | -$37.10 M(+5.7%) |
| Mar 2010 | - | -$5.90 M(-66.3%) | -$35.10 M(+55.3%) |
| Dec 2009 | -$22.60 M(-23.1%) | -$17.50 M(+297.7%) | -$22.60 M(+43.9%) |
| Sept 2009 | - | -$4.40 M(-39.7%) | -$15.70 M(-0.6%) |
| June 2009 | - | -$7.30 M(-210.6%) | -$15.80 M(-44.8%) |
| Mar 2009 | - | $6.60 M(-162.3%) | -$28.60 M(-2.7%) |
| Dec 2008 | -$29.40 M(-134.8%) | -$10.60 M(+135.6%) | -$29.40 M(-23.6%) |
| Sept 2008 | - | -$4.50 M(-77.6%) | -$38.50 M(-37.6%) |
| June 2008 | - | -$20.10 M(-446.6%) | -$61.70 M(+53.1%) |
| Mar 2008 | - | $5.80 M(-129.4%) | -$40.30 M(-147.6%) |
| Dec 2007 | $84.60 M | -$19.70 M(-28.9%) | $84.60 M(-15.8%) |
| Sept 2007 | - | -$27.70 M(-2230.8%) | $100.50 M(-8.6%) |
| June 2007 | - | $1.30 M(-99.0%) | $109.90 M(+36.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | $130.70 M(-3539.5%) | $80.50 M(-233.7%) |
| Dec 2006 | -$60.20 M(-150.0%) | -$3.80 M(-79.2%) | -$60.20 M(+58.8%) |
| Sept 2006 | - | -$18.30 M(-34.9%) | -$37.90 M(-4.8%) |
| June 2006 | - | -$28.10 M(+181.0%) | -$39.80 M(-133.7%) |
| Mar 2006 | - | -$10.00 M(-154.1%) | $118.20 M(-1.9%) |
| Dec 2005 | $120.50 M(-882.5%) | $18.50 M(-191.6%) | $120.50 M(+25.0%) |
| Sept 2005 | - | -$20.20 M(-115.6%) | $96.40 M(-19.8%) |
| June 2005 | - | $129.90 M(-1787.0%) | $120.20 M(-9346.2%) |
| Mar 2005 | - | -$7.70 M(+37.5%) | -$1.30 M(-91.6%) |
| Dec 2004 | -$15.40 M(+27.3%) | -$5.60 M(-255.6%) | -$15.40 M(0.0%) |
| Sept 2004 | - | $3.60 M(-57.1%) | -$15.40 M(-34.2%) |
| June 2004 | - | $8.40 M(-138.5%) | -$23.40 M(-20.7%) |
| Mar 2004 | - | -$21.80 M(+289.3%) | -$29.50 M(+143.8%) |
| Dec 2003 | -$12.10 M(-63.3%) | -$5.60 M(+27.3%) | -$12.10 M(-17.7%) |
| Sept 2003 | - | -$4.40 M(-291.3%) | -$14.70 M(-30.3%) |
| June 2003 | - | $2.30 M(-152.3%) | -$21.10 M(-30.4%) |
| Mar 2003 | - | -$4.40 M(-46.3%) | -$30.30 M(-8.2%) |
| Dec 2002 | -$33.00 M(+108.9%) | -$8.20 M(-24.1%) | -$33.00 M(-39.4%) |
| Sept 2002 | - | -$10.80 M(+56.5%) | -$54.50 M(+45.3%) |
| June 2002 | - | -$6.90 M(-2.8%) | -$37.50 M(+15.4%) |
| Mar 2002 | - | -$7.10 M(-76.1%) | -$32.50 M(+105.7%) |
| Dec 2001 | -$15.80 M(-241.1%) | -$29.70 M(-579.0%) | -$15.80 M(-190.8%) |
| Sept 2001 | - | $6.20 M(-426.3%) | $17.40 M(+1.2%) |
| June 2001 | - | -$1.90 M(-119.8%) | $17.20 M(+352.6%) |
| Mar 2001 | - | $9.60 M(+174.3%) | $3.80 M(-66.1%) |
| Dec 2000 | $11.20 M(+30.2%) | $3.50 M(-41.7%) | $11.20 M(+646.7%) |
| Sept 2000 | - | $6.00 M(-139.2%) | $1.50 M(-122.7%) |
| June 2000 | - | -$15.30 M(-190.0%) | -$6.60 M(-123.7%) |
| Mar 2000 | - | $17.00 M(-374.2%) | $27.90 M(+224.4%) |
| Dec 1999 | $8.60 M(-145.3%) | -$6.20 M(+195.2%) | $8.60 M(-360.6%) |
| Sept 1999 | - | -$2.10 M(-110.9%) | -$3.30 M(-46.8%) |
| June 1999 | - | $19.20 M(-934.8%) | -$6.20 M(-85.1%) |
| Mar 1999 | - | -$2.30 M(-87.3%) | -$41.70 M(+119.5%) |
| Dec 1998 | -$19.00 M(+167.6%) | -$18.10 M(+262.0%) | -$19.00 M(+726.1%) |
| Sept 1998 | - | -$5.00 M(-69.3%) | -$2.30 M(-215.0%) |
| June 1998 | - | -$16.30 M(-179.9%) | $2.00 M(-87.0%) |
| Mar 1998 | - | $20.40 M(-1557.1%) | $15.40 M(-316.9%) |
| Dec 1997 | -$7.10 M(-75.4%) | -$1.40 M(+100.0%) | -$7.10 M(-61.2%) |
| Sept 1997 | - | -$700.00 K(-75.9%) | -$18.30 M(-30.7%) |
| June 1997 | - | -$2.90 M(+38.1%) | -$26.40 M(+3.5%) |
| Mar 1997 | - | -$2.10 M(-83.3%) | -$25.50 M(-11.8%) |
| Dec 1996 | -$28.90 M(-165.8%) | -$12.60 M(+43.2%) | -$28.90 M(+27.9%) |
| Sept 1996 | - | -$8.80 M(+340.0%) | -$22.60 M(+35.3%) |
| June 1996 | - | -$2.00 M(-63.6%) | -$16.70 M(-178.8%) |
| Mar 1996 | - | -$5.50 M(-12.7%) | $21.20 M(-51.7%) |
| Dec 1995 | $43.90 M(+404.6%) | -$6.30 M(+117.2%) | $43.90 M(-22.3%) |
| Sept 1995 | - | -$2.90 M(-108.1%) | $56.50 M(-7.2%) |
| June 1995 | - | $35.90 M(+108.7%) | $60.90 M(+152.7%) |
| Mar 1995 | - | $17.20 M(+173.0%) | $24.10 M(+177.0%) |
| Dec 1994 | $8.70 M(-181.3%) | $6.30 M(+320.0%) | $8.70 M(-293.3%) |
| Sept 1994 | - | $1.50 M(-266.7%) | -$4.50 M(-35.7%) |
| June 1994 | - | -$900.00 K(-150.0%) | -$7.00 M(-20.5%) |
| Mar 1994 | - | $1.80 M(-126.1%) | -$8.80 M(-17.8%) |
| Dec 1993 | -$10.70 M(-43.1%) | -$6.90 M(+590.0%) | -$10.70 M(+64.6%) |
| Sept 1993 | - | -$1.00 M(-63.0%) | -$6.50 M(-47.2%) |
| June 1993 | - | -$2.70 M(+2600.0%) | -$12.30 M(-25.5%) |
| Mar 1993 | - | -$100.00 K(-96.3%) | -$16.50 M(-12.2%) |
| Dec 1992 | -$18.80 M(-3.1%) | -$2.70 M(-60.3%) | -$18.80 M(-21.3%) |
| Sept 1992 | - | -$6.80 M(-1.4%) | -$23.90 M(-4.0%) |
| June 1992 | - | -$6.90 M(+187.5%) | -$24.90 M(+14.7%) |
| Mar 1992 | - | -$2.40 M(-69.2%) | -$21.70 M(+11.9%) |
| Dec 1991 | -$19.40 M(+351.2%) | -$7.80 M(0.0%) | -$19.40 M(+50.4%) |
| Sept 1991 | - | -$7.80 M(+110.8%) | -$12.90 M(+48.3%) |
| June 1991 | - | -$3.70 M(+3600.0%) | -$8.70 M(+210.7%) |
| Mar 1991 | - | -$100.00 K(-92.3%) | -$2.80 M(-34.9%) |
| Dec 1990 | -$4.30 M(-38.6%) | -$1.30 M(-63.9%) | -$4.30 M(+43.3%) |
| Sept 1990 | - | -$3.60 M(-263.6%) | -$3.00 M(-600.0%) |
| June 1990 | - | $2.20 M(-237.5%) | $600.00 K(-137.5%) |
| Mar 1990 | - | -$1.60 M | -$1.60 M |
| Dec 1989 | -$7.00 M | - | - |
FAQ
- What is West Pharmaceutical Services annual cash flow from financing activities?
- What is the all time high annual CFF for West Pharmaceutical Services?
- What is West Pharmaceutical Services annual CFF year-on-year change?
- What is West Pharmaceutical Services quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for West Pharmaceutical Services?
- What is West Pharmaceutical Services quarterly CFF year-on-year change?
- What is West Pharmaceutical Services TTM cash flow from financing activities?
- What is the all time high TTM CFF for West Pharmaceutical Services?
- What is West Pharmaceutical Services TTM CFF year-on-year change?
What is West Pharmaceutical Services annual cash flow from financing activities?
The current annual CFF of WST is -$459.60 M
What is the all time high annual CFF for West Pharmaceutical Services?
West Pharmaceutical Services all-time high annual cash flow from financing activities is $120.50 M
What is West Pharmaceutical Services annual CFF year-on-year change?
Over the past year, WST annual cash flow from financing activities has changed by -$166.00 M (-56.54%)
What is West Pharmaceutical Services quarterly cash flow from financing activities?
The current quarterly CFF of WST is -$64.40 M
What is the all time high quarterly CFF for West Pharmaceutical Services?
West Pharmaceutical Services all-time high quarterly cash flow from financing activities is $130.70 M
What is West Pharmaceutical Services quarterly CFF year-on-year change?
Over the past year, WST quarterly cash flow from financing activities has changed by -$42.10 M (-188.79%)
What is West Pharmaceutical Services TTM cash flow from financing activities?
The current TTM CFF of WST is -$743.20 M
What is the all time high TTM CFF for West Pharmaceutical Services?
West Pharmaceutical Services all-time high TTM cash flow from financing activities is $120.50 M
What is West Pharmaceutical Services TTM CFF year-on-year change?
Over the past year, WST TTM cash flow from financing activities has changed by -$463.60 M (-165.81%)